Melucci
Melucci v. Corcept Therapeutics Incorporated
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT
NORTHERN DISTRICT OF CALIFORNIA
SAN JOSE DIVISION
NICHOLAS MELUCCI, Case No. 19-CV-01372-LHK
Plaintiff,
ORDER APPOINTING LEAD
PLAINTIFF AND LEAD COUNSEL
v. Re: Dkt. Nos. 15, 17, 24, 29, 32, 58 CORCEPT THERAPEUTICS INCORPORATED, et al., 16 Defendants.
This case is a putative securities class action brought against Defendant Corcept Therapeutics Incorporated (“Corcept”); its President and Chief Executive Officer, Joseph K. Belanoff; and its Chief Financial Officer, Charles Robb. Plaintiffs in this action consist of “persons and entities that purchased or otherwise acquired Corcept securities between August 2, 2017 and February 5, 2019, inclusive (the ‘Class Period’).” ECF No. 1 (“Compl.”) ¶ 1. Before the Court are four outstanding Motions for Appointment as Lead Plaintiff and Approval of Lead Counsel. I. BACKGROUND Corcept is a “pharmaceutical company that purports to develop medications to treat severe metabolic, oncologic, and psychiatric disorders by modulating the…